ストックスクリーナーアプリを入手
3.805
9.71%
0.305
前日終値:
$3.50
開ける：
$3.5
24時間の取引高:
35,148
Relative Volume:
0.55
時価総額：
$57.08M
収益：
$37.79M
当期純損益:
$-10.38M
株価収益率:
-5.2123
EPS:
-0.73
ネットキャッシュフロー:
$-1.00M
1週間 パフォーマンス:
+24.47%
1か月 パフォーマンス:
-29.93%
6か月 パフォーマンス:
+38.62%
1年 パフォーマンス:
+163.01%
1日の値動き範囲:
$3.50
$3.8419
1週間の範囲:
$3.00
$3.8419
52週間の値動き範囲:
$1.04
$7.25
Cumberland Pharmaceuticals Inc Stock (CPIX) Company Profile
名前
Cumberland Pharmaceuticals Inc
セクター
電話
615-255-0068
住所
2525 WEST END AVENUE, NASHVILLE,, TN
CPIX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CPIX
Cumberland Pharmaceuticals Inc
|
3.815 | 45.93M | 37.79M | -10.38M | -1.00M | -0.73 |
|
ZTS
Zoetis Inc
|
151.57 | 70.25B | 9.29B | 2.52B | 2.28B | 5.57 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.69 | 47.44B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
HLN
Haleon Plc Adr
|
9.715 | 45.15B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
15.88 | 19.07B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
298.18 | 13.28B | 2.99B | 1.21B | 1.13B | 25.06 |
Cumberland Pharmaceuticals Inc Stock (CPIX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2012-11-12 | 繰り返されました | UBS | Neutral |
| 2011-02-01 | 繰り返されました | UBS | Neutral |
| 2010-12-16 | ダウングレード | UBS | Buy → Neutral |
| 2010-08-17 | ダウングレード | Jefferies | Buy → Hold |
| 2010-08-17 | 繰り返されました | Morgan Joseph | Buy |
| 2010-08-17 | 繰り返されました | UBS | Buy |
| 2010-05-14 | 繰り返されました | Morgan Joseph | Buy |
すべてを表示
Cumberland Pharmaceuticals Inc (CPIX) 最新ニュース
Why Cumberland Pharmaceuticals Inc. stock attracts strong analyst attentionROI Driven Alerts - Newser
How Cumberland Pharmaceuticals Inc. stock performs during market volatilityBest Stocks for Capital Safety - Newser
What makes Cumberland Pharmaceuticals Inc. stock price move sharplyChart Breakout Alert - Newser
Caroline Young of Cumberland Pharmaceuticals buys CPIX shares By Investing.com - Investing.com Nigeria
Caroline Young of Cumberland Pharmaceuticals buys CPIX shares - Investing.com Australia
Cumberland Pharma CEO A J Kazimi buys shares worth $807 - Investing.com Australia
Cumberland Pharma CEO A J Kazimi buys shares worth $807 By Investing.com - Investing.com South Africa
Cumberland Pharmaceuticals Advances Ifetroban Study for SSc and SSc-PAH - The Globe and Mail
Cumberland Pharmaceuticals Inc.(NasdaqGS:CPIX) added to Russell Microcap Growth Index - MarketScreener
Cumberland reports positive DMD heart drug trial results - Investing.com India
Asthma Market to Expand Significantly by 2034, States - openPR.com
Asthma Market to Expand Significantly by 2034, States DelveInsight Report | GSK, AB Science, Areteia Therapeutics, ARS Pharma, AstraZeneca, Pieris Pharma, Sanofi, Cumberland Pharma, Genentech - Barchart.com
Two Sigma Investments LP Has $89,000 Stake in Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) - Defense World
Cumberland Pharmaceuticals (NASDAQ:CPIX) Shares Cross Above Two Hundred Day Moving Average – Here’s Why - Defense World
Cumberland pharmaceuticals director Kenneth Krogulski acquires $4,824 in stock By Investing.com - Investing.com South Africa
Cumberland pharmaceuticals director Kenneth Krogulski acquires $4,824 in stock - Investing.com
Dilated Cardiomyopathy Market Witnesses Robust Growth During the Study Period (2020–2034) Amid Advancements in Cardiovascular Therapies | DelveInsight - GlobeNewswire Inc.
Cumberland Pharmaceuticals (NASDAQ:CPIX) Share Price Passes Above 200 Day Moving Average – Time to Sell? - Defense World
Investors in Cumberland Pharmaceuticals (NASDAQ:CPIX) have seen splendid returns of 235% over the past year - Yahoo
NEW STUDY FINDS CALDOLOR® SAFE AND EFFECTIVE FOR OPIOID-SPARING PAIN MANAGEMENT IN OLDER ADULTS - PR Newswire
Cumberland Pharmaceuticals (NASDAQ:CPIX) Share Price Passes Above Two Hundred Day Moving Average – Here’s Why - Defense World
Q&A: Cumberland Pharmaceuticals CEO A.J. Kazimi weighs in on industry challenges, strengths - The Business Journals
Cumberland CEO A.J. Kazimi: Pharmaceutical tariffs would be 'concerning' - The Business Journals
Dimensional Fund Advisors LP Cuts Stock Position in Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) - Defense World
Cumberland Pharmaceuticals Reports 38% Revenue Growth in Q1 2025 - The Victoria Advocate
Cumberland, Qureight Collaborate on Lung Disease Treatment Trial - marketscreener.com
CUMBERLAND PHARMACEUTICALS PARTNERS WITH QUREIGHT TO ADVANCE INNOVATIVE IDIOPATHIC PULMONARY FIBROSIS TREATMENT RESEARCH - PR Newswire
Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) Q1 2025 Earnings Call Transcript - Insider Monkey
Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) Held Back By Insufficient Growth Even After Shares Climb 30% - simplywall.st
Cumberland Pharmaceuticals Reports Strong Q1 2025 Earnings - TipRanks
Cumberland Pharmaceuticals (NASDAQ:CPIX) Stock Rating Upgraded by StockNews.com - Defense World
Cumberland Pharmaceuticals Reports Strong Q1 2025 Growth - TipRanks
Cumberland Pharmaceuticals Inc (CPIX) Q1 2025 Earnings Call Highlights: Strong Revenue Growth ... By GuruFocus - Investing.com Canada
Cumberland: Q1 Earnings Snapshot - MySA
Cumberland Pharmaceuticals Inc Reports Q1 2025 Earnings: EPS at $0.16, Revenue Hits $11.7 Million - GuruFocus
Earnings call transcript: Cumberland Pharmaceuticals sees Q1 2025 revenue jump 38% - Investing.com
Cumberland Pharmaceuticals Inc.Common Stock (NQ: CPIX - FinancialContent
Renaissance Technologies LLC Sells 21,000 Shares of Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) - Defense World
CUMBERLAND PHARMACEUTICALS TO ANNOUNCE Q1 2025 FINANCIAL RESULTS & COMPANY UPDATE - marketscreener.com
Cumberland Pharmaceuticals Shareholders Approve Key Proposals By Investing.com - Investing.com India
Cumberland Pharmaceuticals Shareholders Approve Key Proposals - Investing.com
Press Release Distribution & PR Platform - ACCESS Newswire
Cumberland Pharmaceuticals Inc (CPIX) 財務データ
収益
当期純利益
現金流量
EPS
6.71%
0.62%
大文字化:
|
ボリューム (24 時間):